HOME
HIV and AIDS
Hepatitis B
Hepatitis C
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV and AIDS Articles on:
  FDA-approved Treatments
 
Experimental Treatments
 
Top New Articles
HOME PAGE

Opportunistic Infections
Tuberculosis / Candidiasis / Pneumonia
CMV Retinitis

Updated Guidelines for Prevention and Treatment of Opportunistic Infections in HIV Positive Adults, Adolescents, and Children

Despite HAART, People with HIV Are Still At Risk for Life-threatening Progressive Multifocal Leukoencephalopathy (PML) - 9/12/2008

Cidofovir (Vistide) in Addition to Antiretroviral Therapy Is Not Effective for AIDS-related Progressive Multifocal Leukoencephalopathy (PML) - 9/12/2008

High HIV Viral Load Is a Risk Factor for Tuberculosis within 3 Months of Starting HAART - 8/26/08

Tuberculosis, HAART, and Survival in the THRio Cohort in Rio de Janerio, Brazil - 8/26/08

ournal Examines Treatment of Extensively Drug-resistant Tuberculosis as First Survey of Cases Is Reported in California - 8/26/08

Nevirapine (Viramune) May Be Less Effective When Combined with Tuberculosis Treatment - 8/05/08

Tuberculosis Presents Major Challenges to HIV Treatment in Developing Countries - 7/25/08

Studies Show High Rates of Cancer-causing Human Papillomavirus Infection among HIV Positive Women in Africa - 7/15/08

Key Tuberculosis (TB) Drug Isoniazid Fails to Protect Infants of HIV Positive Mothers from TB Acquisition or Death - 7/18/08

New Test Can Rapidly Diagnose Multidrug-resistant Tuberculosis - 7/08/08

HAART Regimen Changes Due to Drug Toxicities in HIV Positive People with Virological Suppression - 6/13/08


HIV Patients Taking Efavirenz (Sustiva) Experience Fewer Oral Lesions than Those on Protease Inhibitors - 6/13/08

Anti-PGL-TB-1 Antibodies Predict Lack of Immune Restoration Syndrome in HIV Positive Patients with Tuberculosis - 6/06/08

Bacterial Vaginosis, Not HIV, Is Primarily Responsible for Increased Concentrations of Vaginal Proinflammatory Cytokines - 6/03/08

Oral Therapy Reduces Incidence of Bacterial Vaginosis and Promotes Vaginal Health in HIV Positive Women - 6/03/08

Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection - 6/03/08

Gastrointestinal Symptoms
Are Uncommon during Early HIV Infection, Despite CD4 Cell Depletion in the Gut - 5/23/08

Inflammatory Bowel Disease in HIV Positive Individuals - 5/23/08

Higher CD4 Count Predicts Lower Risk of AIDS-related and Non-AIDS Illness, even above 350 Cells/mm3 - 5/06/08

NIAID Research Priorities to Fight Drug-resistant Tuberculosis - 5/06/08

Treatment Options for Osteopenia and Osteoporosis in HIV Patients - 5/02/08

Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Protease Inhibitors (PIs)
Note: Most PIs are now used in combination with low-dose ritonavir (Norvir)
Agenerase
Agenerase (amprenavir)
Aptivus
Aptivus (tipranavir)
Crixivan
Crixivan (indinavir)
Invirase
Invirase (saquinavir )
Kaletra
Kaletra (lopinavir/ritonavir)
Lexiva
Lexiva (fosamprenavir)
Norvir
Norvir (ritonavir)
Prezista
Prezista (darunavir)
Reyataz
Reyataz (atazanavir)
Viracept
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
Combivir
Combivir (zidovudine + lamivudine)
Epivir
Epivir (lamivudine; 3TC)
Emtriva
Emtriva (emtricitabine; FTC)
Epzicom
Epzicom (abacavir + lamivudine)
Retrovir
Retrovir (zidovudine; AZT)
Trizivir
Trizivir (abacavir + zidovudine +lamivudine)
Truvada
Truvada  (tenofovir + emtricitabine)
Videx
Videx (didanosine; ddI)
Viread
Viread (tenofovir)
Zerit
Zerit (stavudine; d4T)
Ziagen
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase  Inhibitors
(nNRTIs)
Rescriptor
Intelence (etravirine)
Rescriptor
Rescriptor (delavirdine)
Sustiva
Sustiva (efavirenz)
Viramune
Viramune (nevirapine)
Entry / Fusion Inhibitors
Fuzeon (enfuvirtide)
Selzentry/Celsentri ( maraviroc)
Fixed-dose Combinations
Atripla
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir
Combivir (zidovudine + lamivudine)
Trizivir
Trizivir (abacavir + zidovudine + lamivudine)
Truvada
Truvada (tenofovir + emtricitabine)
Integrase Inhibitors
Isentress (raltegravir)